9 Meters Biopharma Inc. (INNT) Stock Price, Forecast & Analysis
USA - NASDAQ:INNT -
INNT Key Statistics, Chart & Performance
The current stock price of INNT is 0.56 null. In the past month the price increased by 19.15%. In the past year, price decreased by -64.33%.
INNT Latest News, Press Relases and Analysis
About INNT
Company Profile
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
Company Info
9 Meters Biopharma Inc.
8480 HONEYCUTT ROAD SUITE 120
RALEIGH NC 27615
CEO: Sandeep Laumas
Phone: 919-275-1933
9 Meters Biopharma Inc. / INNT FAQ
What does 9 Meters Biopharma Inc. do?
Innovate Biopharmaceuticals, Inc. is a clinical stage biotechnology company. It focused on developing novel medicines for autoimmune/ inflammatory disease. The company's pipeline includes drug candidates for celiac disease, an unmet need, and ulcerative colitis. Its products includes INN-202 for the treatment of Celiac Disease with fast track designation, INN-108 for Inflammatory Bowel Disorders, mild to moderate Ulcerative Colitis and a GI orphan disease in a convenient liquid formulation, INN-329 for Magnetic Resonance Cholangiopancreatography which are in clinical stages. Innovate Biopharmaceuticals Inc., formerly known as Monster Digital, Inc., is based in SIMI VALLEY, United States.
What is the current price of INNT stock?
The current stock price of INNT is 0.56 null. The price decreased by -20.23% in the last trading session.
Does INNT stock pay dividends?
INNT does not pay a dividend.
How is the ChartMill rating for 9 Meters Biopharma Inc.?
INNT has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is 9 Meters Biopharma Inc. (INNT) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on INNT.
INNT Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to INNT. When comparing the yearly performance of all stocks, INNT is a bad performer in the overall market: 85.55% of all stocks are doing better.
INNT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to INNT. INNT may be in some trouble as it scores bad on both profitability and health.
INNT Financial Highlights
Over the last trailing twelve months INNT reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS increased by 91.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -510.66% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |